BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Prognosis
37 results:

  • 1. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
    Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in gastric cancer.
    Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
    Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis.
    Xing J; Chen J; You T; Sun Z; Lu T; Cheng Y; Wu H; Bai C
    J Neuroendocrinol; 2023 Apr; 35(4):e13257. PubMed ID: 36964649
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis.
    Centonze G; Maisonneuve P; Prinzi N; Pusceddu S; Albarello L; Pisa E; Barberis M; Vanoli A; Spaggiari P; Bossi P; Cattaneo L; Sabella G; Solcia E; La Rosa S; Grillo F; Tagliabue G; Scarpa A; Papotti M; Volante M; Mangogna A; Del Gobbo A; Ferrero S; Rolli L; Roca E; Bercich L; Benvenuti M; Messerini L; Inzani F; Pruneri G; Busico A; Perrone F; Tamborini E; Pellegrinelli A; Kankava K; Berruti A; Pastorino U; Fazio N; Sessa F; Capella C; Rindi G; Milione M
    Neuroendocrinology; 2023; 113(4):457-469. PubMed ID: 36417840
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
    Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
    Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploratory genomic analysis of high-grade neuroendocrine neoplasms across diverse primary sites.
    Sun TY; Zhao L; Van Hummelen P; Martin B; Hornbacker K; Lee H; Xia LC; Padda SK; Ji HP; Kunz P
    Endocr Relat Cancer; 2022 Dec; 29(12):665-679. PubMed ID: 36165930
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MiR-192-5p/rb1/NF-κBp65 signaling axis promotes IL-10 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironment.
    Song J; Lin Z; Liu Q; Huang S; Han L; Fang Y; Zhong P; Dou R; Xiang Z; Zheng J; Zhang X; Wang S; Xiong B
    Clin Transl Med; 2022 Aug; 12(8):e992. PubMed ID: 35969010
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancer.
    Hong YH; Aziz N; Park JG; Lee D; Kim JK; Kim SA; Choi W; Lee CY; Lee HP; Huyen Trang HT; Kim HG; Jeon YJ; Kim B; Kim Y; Kim KH; Yoo BC; Han JW; Parameswaran N; Kim JH; Hur H; Cho JY
    Cancer Lett; 2022 Sep; 544():215803. PubMed ID: 35753528
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple cancer Types.
    Tan F
    Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs.
    Shi M; Fan Z; Xu J; Yang J; Li Y; Gao C; Su P; Wang X; Zhan H
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188637. PubMed ID: 34678439
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
    Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
    Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MiR-3663-3p Inhibits the Progression of gastric cancer Through the CCND1 Pathway.
    Takao K; Konishi H; Matsubara D; Shoda K; Arita T; Shimizu H; Komatsu S; Shiozaki A; Yamamoto Y; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Anticancer Res; 2021 May; 41(5):2441-2449. PubMed ID: 33952469
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Liverani C; Bongiovanni A; Mercatali L; Pieri F; Spadazzi C; Miserocchi G; Di Menna G; Foca F; Ravaioli S; De Vita A; Cocchi C; Rossi G; Recine F; Ibrahim T
    Endocr Pathol; 2021 Jun; 32(2):309-317. PubMed ID: 33409812
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancer.
    Bae HJ; Kang SK; Kwon WS; Jeong I; Park S; Kim TS; Kim KH; Kim H; Jeong HC; Chung HC; Rha SY
    Biochem Pharmacol; 2021 Jan; 183():114320. PubMed ID: 33161023
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study.
    Gerard L; Garcia J; Gauthier A; Lopez J; Durand A; Hervieu V; Lemelin A; Chardon L; Landel V; Gibert B; Lombard-Bohas C; Payen L; Walter T
    Neuroendocrinology; 2021; 111(10):951-964. PubMed ID: 33099543
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma.
    Yamashita S; Abe H; Kunita A; Yamashita H; Seto Y; Ushiku T
    Histopathology; 2021 Feb; 78(3):381-391. PubMed ID: 32767778
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. gastric squamous-columnar junction contains a large pool of cancer-prone immature osteopontin responsive Lgr5
    Fu DJ; Wang L; Chouairi FK; Rose IM; Abetov DA; Miller AD; Yamulla RJ; Schimenti JC; Flesken-Nikitin A; Nikitin AY
    Nat Commun; 2020 Jan; 11(1):84. PubMed ID: 31901081
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
    Fan HN; Zhu MY; Peng SQ; Zhu JS; Zhang J; Qu GQ
    Pathol Res Pract; 2020 Feb; 216(2):152795. PubMed ID: 31879047
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
    Klöppel G
    Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Role of ferroptosis in hepatocellular carcinoma.
    Nie J; Lin B; Zhou M; Wu L; Zheng T
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2329-2337. PubMed ID: 30167889
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.